Extracorporeal photopheresis (ECP) is an autologous cell therapy that is widely used for the
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …

Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after
receiving FDA approval for the palliative treatment of the Sézary Syndrome variant of …

Extracorporeal photopheresis (ECP) is a cell-based immunotherapy that involves the
reinfusion of autologous leukocytes after exposure to psoralen and UVA. The treatment has …

Extracorporeal photopheresis (ECP) is a well‐tolerated procedure that suppresses T‐
lymphocyte activity in a clonally‐specific way. It is an effective therapy that has established …

We are now aware that extracorporeal photopheresis (ECP)–in which a patient's leukocytes
are isolated, passed through an ultrathin clear plastic plate, and exposed to 8 …

Introduction: Extracorporeal photopheresis (ECP) has been extensively used for the
treatment of immune-mediated diseases for over 20 years and has a consistent and …

Extracorporeal phototherapy (ECP) is a therapeutic approach based on the biological effect
of psoralen 8-methoxypsoralen (8-MOP) and ultraviolet light A (UVA) on mononuclear cells …

Graft-versus-host disease (GVHD) is a major cause of mortality and morbidity following
allogeneic hematopoietic stem cell transplantation. Extracorporeal photopheresis (ECP) …

Address correspondence to: Zelma C. Chiesa-Fuxench, Department of Dermatology,
University of Puerto Rico School of Medicine, PO Box 365067 San Juan, Puerto Rico 00936 …

Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for malignant
haematological diseases. Despite continuous improvements in pre-and post-transplantation …